[1]李丽霞,李 娜.血清MAO 和IL-6 水平诊断慢性肾衰竭并发心力衰竭的价值及与心功能分级的关系[J].现代检验医学杂志,2023,38(01):147-150+164.[doi:10.3969/j.issn.1671-7414.2023.01.027]
　LI Li-xia,LI Na.Value of Serum MAO and IL-6 Levels in the Diagnosis of Chronic Renal Failure Complicated with Heart Failure and Their Relationship with Cardiac Function Grading[J].Journal of Modern Laboratory Medicine,2023,38(01):147-150+164.[doi:10.3969/j.issn.1671-7414.2023.01.027]
点击复制

血清MAO 和IL-6 水平诊断慢性肾衰竭并发心力衰竭的价值及与心功能分级的关系()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
147-150+164
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Value of Serum MAO and IL-6 Levels in the Diagnosis of Chronic Renal Failure Complicated with Heart Failure and Their Relationship with Cardiac Function Grading
文章编号:
1671-7414（2023）01-147-05
作者:
李丽霞;  李 娜
（邯郸明仁医院检验科，河北邯郸 056002）
Author(s):
LI Li-xia;  LI Na
（Department of Clinical Laboratory, Handan Mingren Hospital，Hebei Handan 056002，China）
关键词:
心力衰竭; 心功能分级; 单胺氧化酶; 慢性肾衰竭
分类号:
R692.5；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.01.027
文献标志码:
A
摘要:
目的 研究血清单胺氧化酶（monoamine oxidase，MAO）、白细胞介素（interleukin，IL）-6 水平与慢性肾衰竭（chronic renal failure）并发心力衰竭（heart failure）患者心功能分级的相关性。方法 选择2021 年6 月～ 2022年5 月邯郸明仁医院肾病科及透析中心慢性肾衰竭并发心力衰竭患者80 例作为试验组，按照美国纽约心脏病学会（New York Heart Association，NYHA）分级将试验组患者分为：心功能I 级20 例，心功能II 级20 例，心功能III 级20 例和心功能IV 级20 例，同期选择单纯慢性肾衰竭患者80 例作为对照A 组，健康体检者80 例作为对照B 组，分别测定各组的血清MAO，IL-6 和N- 末端B 型钠尿肽前体（N-terminal B-type natriuretic peptide precursor，NTproBNP）水平，分析其与慢性肾衰竭并发心力衰竭患者心功能分级的关系。其中试验组、对照A 组符合疾病诊断标准，经各项检查确诊，且病情稳定，实验前均未接受治疗，另外所有观察对象与家属签订知情书。结果 试验组MAO（8.56±1.85U/L），IL-6（128.56±17.48ng/L）和NT-proBNP（872.04±11.25pg/ml）水平均高于对照A 组（3.14±1.01U/L，97.42±12.36ng/L，195.79±6.87pg/ml） 和对照B 组（2.87±0.85U/L，77.69±8.15ng/L，66.04±5.48pg/ml）， 差异均具有统计学意义（F=478.790，300.850，220 577.310，均 P ＜ 0.05）。心功能I 级MAO，IL-6，NT-proBNP 水平分别为3.77±1.05U/L，104.26±15.47ng/L 和381.25±8.44pg/ml， 心功能II 级MAO，IL-6，NT-proBNP 水平分别为5.26±1.35U/L，113.15±16.89ng/L 和579.31±10.10pg/ml，心功能III 级MAO，IL-6，NT-proBNP 水平分别为7.48±2.09U/L，125.73±17.02ng/L 和782.08±11.24pg/ml， 心功能IV 级MAO，IL-6，NT-proBNP 水平分别为8.99±2.67U/L，130.58±17.96ng/L，901.54±12.10pg/ml，试验组中心功能IV 级患者的血清MAO，IL-6，NT-proBNP 水平均高出心功能I，II，III 级患者，差异具有统计学意义（F=29.750，172.220，9 414.430, 均P ＜ 0.05）。联合诊断的敏感度（97.50%）、特异度（95.00%）、ROC 曲线下面积（0.893）高出单一MAO（86.25%，83.75%，0.600）和IL-6（87.50%，83.75%，0.580），差异具有统计学意义（χ2=0.004，7.207，6.664，均P ＜ 0.05）。血清MAO，IL-6，NT-proBNP 指标均与慢性肾衰竭并发心力衰竭患者心功能分级呈现正相关性（r=0.562 ～ 0.781，P ＜ 0.05）。结论 血清MAO，IL-6 与慢性肾衰竭并发心力衰竭患者心功能分级存在密切关联性，不仅能够诊断疾病，同时还可对心功能分级进行评估，另外联合诊断的敏感度以及特异度更高。
Abstract:
Objective To study the correlation of serum monoamine oxidase (MAO) and interleukin-6 (IL-6) levels with cardiac function classifications in chronic renal failure patients with heart failure. Methods 80 chronic renal failure patients with heart failure treated from June 2021 to May 2022 in Nephrology and Dialysis Department of Handan Mingren Hospital were chosen as experimental group. According to New York Heart Association (NYHA), the experimental group was assigned to grade I group (20 cases), grade II group (20 cases), grade III group (20 cases) and grade IV group (20 cases). Over the same time period, 80 chronic renal failure patients were set as control group A. 80 healthy checkups were set as control group B. Serum MAO, IL-6 and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were measured, and analyze its correlations with cardiac function classifications. Among them, the test group and the control group A met the disease diagnostic criteria; were confirmed by various examinutions, and were in a stable comdition, and did not receive treatment before the experiment. In addition, all the observation objects signed a love letter with their familes receive the therapy; the research subjects and their family members had signed the informed consent forms. Results Serum MAO(8.56±1.85U/L), IL-6(128.56±17.48ng/L ) and NT-proBNP (872.04±11.25pg/ml) levels in the experimental group were, and which were significantly higher than those of control group A (3.14±1.01U/L, 97.42±12.36ng/L, 195.79±6.87pg/ml)]and control group B (2.87±0.85U/L, 77.69±8.15ng/L, 66.04±5.48pg/ml)]，the differences were statistically significant（F=478.790，300.850，220 577.310，all P ＜ 0.05）. Serum MAO, IL-6 and NT-proBNP levels in grade I group were 3.77±1.05U/L, 104.26±15.47ng/L and 381.25±8.44pg/ml， respectively. Serum MAO, IL-6 and NT-proBNP levels in grade II group were 5.26±1.35U/L, 113.15±16.89ng/L and 579.31±10.10pg/ml，respectively. Serum MAO,IL-6 and NT-proBNP levels in grade III group were 7.48±2.09U/L, 125.73±17.02ng/L and 782.08±11.24pg/ml，respectively. Serum MAO, IL-6 and NT-proBNP levels in grade IV group were 8.99±2.67U/L, 130.58±17.96ng/L and 901.54±12.10 pg/ml，respectively. Serum MAO, IL-6 and NT-proBNP levels in grade IV group were significantly higher than grade I group, grade II group and grade III group （F=29.750，172.220，9 414.430, all P ＜ 0.05）. The diagnosis sensitivity（97.50%）, specificity（95.00%） and area under ROC（0.893） curve based on combined examination were higher than those based on MAO（86.25%，83.75%，0.600） or IL-6（87.50%，83.75%，0.580）, the differences were statistically significant（χ2=0.004，7.207，6.664，all P ＜ 0.05）.Serum MAO, IL-6 and NT-proBNP levels were positively correlated with cardiac function classifications for chronic renal failure patients with heart failure (r=0.562 ～ 0.781，all P ＜ 0.05). Conclusion Serum MAO and IL-6 levels were closely correlated with cardiac function classifications in chronic renal failure patients with heart failure, which can make for disease diagnosis and evaluate the cardiac function classifications; the diagnosis sensitivity and specificity based on combined examination are higher than single examination.

参考文献/References:

[1] 祝存奎, 朱芳一, 戴婧, 等. 青海高原地区不同海拔世居藏族和汉族慢性心力衰竭患者血清N 末端脑钠肽前体、超敏C 反应蛋白及炎性因子水平变化及其与预后的关系研究[J]. 实用心脑肺血管病杂志,2020, 28(4): 28-33．
ZHU Cunkui, ZHU Fangyi, DAI Jing, et al. Changes and relations to prognosis of serum levels of NTproBNP,hs-CRP and inflammatory cytokines in Zang and Han nationality chronic heart failure patients with different living altitude in Qinghai plateau [J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2020,28 (4): 28-33.
[2] 唐欢, 徐琨, 王艳, 等．IL-6 与PCT 及NEU% 在慢性肾衰竭合并细菌感染患者的诊断价值[J]. 中华医院感染学杂志, 2019, 29(13): 1967-1970．
TANG Huan, XU Kun, WANG Yan, et al. Value of IL-6, PCT and NEU% in diagnosis of chronic renal failure patients complicated with bacterial infection[J].Chinese Journal of Nosocomiology, 2019,29 (13):1967-1970.
[3] 杨银忠, 赵鹃, 程文霞, 等. 血清IL-6, hs-CRP 和PTH 联合检测在急, 慢性肾衰竭鉴别诊断中的价值[J]. 中国老年学杂志, 2017, 37(17): 4349-4351．
YANG Yinzhong, ZHAO Juan, CHENG Wenxia, et al. The value of differential diagnosis of combined detection of serum IL-6,hs-CRP and PTH on acute and chronic renal failure [J].Chinese Journal of Gerontology, 2017, 37 (17): 4349-4351
[4] 刘锐, 颜廷立, 高延庆. 心衰合并急性肾衰竭患者尿L-FABP,IL-18 表达与预后的相关性[J]．河北医药,2019, 41(16): 2487-2489, 2493．
LIU Rui, YAN Tingli, GAO Yanqing. Correlation between the expressions of urinary L-FABP,serum IL-18 and the prognosis of patients with heart failure complicated by acute renal failure [J]. Hebei Medical Journal, 2019,41 (16): 2487-2489, 2493.
[5] 于辉, 赵阳, 费家玥, 等．血清MIP-2,PCT 及IL-6水平对心力衰竭合并肺部感染的诊断价值[J]. 中华医院感染学杂志, 2020, 30(16): 2448-2451．
YU Hui, ZHAO Yang, FEI Jiayue, et al. Diagnostic value of serum MIP-2, PCT and IL-6 levels in patients with heart failure and pulmonary infection [J]. Chinese Journal of Nosocomiology, 2020,30 (16): 2448-2451.
[6] 葛均波, 徐永健．内科学[M]．8 版．北京：人民卫生出版社, 2013：227-255, 741-742．
GE Junbo, XU Yongjian. Internal medicine [M]. 8th Edition. Beijing: People’s Health Publishing House,2013:227-255, 741-742.
[7] 花蕊, 张翠柳, 黄志勇. 心力衰竭合并肺部感染患者的细菌学特征及CHE,IL-6,PCT,NT-proBNP/BNP 比值水平变化及意义研究[J]．湖南师范大学学报(医学版), 2020, 17(5): 135-138．
HUA Rui, ZHANG Cuiliu, HUANG Zhiyong. Bacteriological characteristics and significance of CHE,IL-6, PCT, NT-proBNP/BNP ratio in patients with heart failure complicated with pulmonary infection [J].Journal of Hunan Normal University(Medical Science),2020,17 (5): 135-138.
[8] 徐万忠, 白艳丽, 王晓麒．白细胞介素6 基因多态性对老年严重心力衰竭患者预后的预测作用[J]．中华老年心脑血管病杂志, 2020, 22(7): 722-724．
XU Wanzhong, BAI Yanli, WANG Xiaoqi. Role of IL-6 gene polymorphism in predicting prognosis of elderly severe heart failure patients [J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2020,22 (7):722-724.
[9] 熊秋璨, 钟灵, 付静, 等．慢性心力衰竭患者血清sST2,IL-6 和肽素水平的变化及临床意义[J]．现代生物医学进展, 2018, 18(24): 4673-4676．
XIONG Qiucan, ZHONG Ling, FU Jing, et al. Changes and clinical significance of serum levels of sST2, IL-6 and peptide in patients with chronic heart failure [J].Progress in Modern Biomedicine, 2018,18 (24): 4673-4676.
[10] 任继欣, 郭彦言. 外周血HBP, IL-6, CD64 指数,PCT, CRP 和SAA 水平检测在血流感染诊断中的应用价值研究[J]. 现代检验医学杂志, 2020, 35(2):56-59．
REN Jixin, GUO Yanyan. Application value of peripheral blood HBP, Interleukin-6, CD64 index, PCT,CRP,SAA level detection in blood stream infection diagnosis [J]. Journal of Modern Laboratory Medicine,2020,35 (2): 56-59.
[11] 莉敏, 方斌, 方海啸, 等．单胺氧化酶A/B 亚型的活性检测在神经系统疾病诊疗中的应用[J]. 中国临床药理学与治疗学, 2020, 25(9): 1052-1058．
WANG Limin, FANG Bin, FANG Haixiao, et al.Application of activity detection of monoamine oxidase A/B subtype in diagnosis and treatment of nervous system diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020,25(9): 1052-1058.
[12] 李斌, 张鹏．血清透明质酸, IV 型胶原, 单胺氧化酶及转化生长因子β1 联合检测对肝纤维化的诊断价值分析[J]. 实用医院临床杂志, 2019, 16(5): 37-39.
LI Bin, ZHANG Peng. The diagnostic value of combined detection of serum HA, Ⅳ -C,MAO and TGF-β1 for liver fibrosis [J]. Practical Journal of Clinical Medicine, 2019,16 (5): 37-39.
[13] 阚民强, 杨润华, 时良玺, 等．单胺氧化酶B 抑制剂对急性脑出血患者APACHE Ⅱ评分和GCS 评分的影响[J]. 脑与神经疾病杂志, 2017, 25(11): 704-706.
KAN Minqiang, YANG Runhua, SHI Liangxi, et al.Effect of APACHE Ⅱ and GCS scores in patients with acute intracerebral hemorrhage by monoamine oxidase B inhibitor [J]. Journal of Brain and Nervous Diseases,2017,25 (11): 704-706.
[14] WANG Tao, GAO Wen, XIAO Kun, et al. Interaction between interleukin-6 and angiotensin II receptor 1 in the hypothalamic paraventricular nucleus contributes to progression of heart failure[J]. Molecular Medicine Reports, 2017, 15(6): 4259-4265.
[15] 王大强, 王革新, 张庆远, 等．血清TNF-α 与IL-6和BNP 指标在检测心力衰竭合并感染患者中的应用价值分析[J]．中华医院感染学杂志, 2018, 28(21):3219-3221．
WANG Daqiang, WANG Gexin, ZHANG Qingyuan, et al. Value of serum TNF-α,IL-6 and BNP in diagnosis of heart failure patients complicated with infection[J]. Chinese Journal of Nosocomiology, 2018,28 (21):3219-3221,3125.

相似文献/References:

[1]丁春梅,胡志德,刘晓斐,等.MR-proANP：一种新型心力衰竭诊断标志物[J].现代检验医学杂志,2015,30(05):99.[doi:10.3969/j.issn.1671-7414.2015.05.0030]
　DING Chun-mei,HU Zhi-de,LIU Xiao-fei,et al.MR-proANP：A Novel Diagnostic Marker for Heart Failure[J].Journal of Modern Laboratory Medicine,2015,30(01):99.[doi:10.3969/j.issn.1671-7414.2015.05.0030]
[2]闫福堂,苏宝凤,詹颉,等.血清可溶性ST2与血BNP在心力衰竭患者中的相关性研究[J].现代检验医学杂志,2015,30(06):78.[doi:10.3969/j.issn.1671-7414.2015.06.022]
　YAN Fu-tang,SU Bao-feng,ZHAN Jie,et al.Correlation between Serum Soluble ST2 and BNP in Patients with Heart Failure[J].Journal of Modern Laboratory Medicine,2015,30(01):78.[doi:10.3969/j.issn.1671-7414.2015.06.022]
[3]王 璐,李维娟,杨 靖.血清NT-proBNP和Cys-C水平联合检测在心力衰竭诊断与分型中的应用[J].现代检验医学杂志,2018,33(06):91.[doi:10.3969/j.issn.1671-7414.2018.06.024]
　WANG Lu,LI Wei-juan,YANG Jing.Application of Combined Detection of Serum NT-proBNP and Cys-C Levels in Diagnosis and Typing of Heart Failure[J].Journal of Modern Laboratory Medicine,2018,33(01):91.[doi:10.3969/j.issn.1671-7414.2018.06.024]
[4]屈慧,李娅,黄瑶楠,等.心力衰竭患者外周血RDW 和NT-pro-BNP 联合检测对临床诊断及分级的相关性研究[J].现代检验医学杂志,2020,35(05):65.[doi:10.3969/j.issn.1671-7414.2020.05.017]
　QU Hui,LI Ya,HUANG Yao-nan,et al.Correlation Study on the Combined Detection of RDW and NT-Pro-BNP in Patients with Heart Failure to Clinical Diagnosis and Grading[J].Journal of Modern Laboratory Medicine,2020,35(01):65.[doi:10.3969/j.issn.1671-7414.2020.05.017]
[5]易福凌,陈伟芝,王　禺.慢性心力衰竭患者血清 Mb，cTnI，IL-8 和 hs-CRP 水平表达与心功能分级的相关性研究[J].现代检验医学杂志,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
　YI Fu-ling,CHEN Wei-zhi,WANG Yu.Correlation between the Expression of Serum MB, cTnI, IL-8, hs-CRP andCardiac Function in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(01):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
[6]胡小燕,郑　晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
　HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[7]李志强,吴正霞,陈　凯,等.心力衰竭患者并发甲型流感的临床和实验室特征分析[J].现代检验医学杂志,2021,36(03):137.[doi:10.3969/j.issn.1671-7414.2021.03.031]
　LI Zhi-qianga,WU Zheng-xiaa,CHEN Kaia,et al.Analysis on the Clinical and Laboratory Characteristics of Heart FailurePatients with Influenza A[J].Journal of Modern Laboratory Medicine,2021,36(01):137.[doi:10.3969/j.issn.1671-7414.2021.03.031]
[8]杨　英,吴　翔,张文华,等.川芎嗪通过调控组蛋白乙酰化修饰上调SERCA2a对心力衰竭小鼠模型的防治机制研究[J].现代检验医学杂志,2021,36(06):34.[doi:10.3969/j.issn.1671-7414.2021.06.007]
　YANG Ying,WU Xiang,ZHANG Wen-hua,et al.Research on Prevention and Control Mechanism of the Ligustrazine Up Regulates SERCA2a by Regulating Histone Acetylation in A Mouse Model of Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(01):34.[doi:10.3969/j.issn.1671-7414.2021.06.007]
[9]张 囝a,徐钰行b,骆宇琛c,等.重症肺炎脓毒症患者血清Sestrin2，TLR7 水平表达及对心力衰竭的预测价值分析[J].现代检验医学杂志,2024,39(03):131.[doi:10.3969/j.issn.1671-7414.2024.03.022]
　ZHANG Jiana,XU Yuxingb,LUO Yuchenc,et al.Analysis of Serum Sestrin2 and TLR7 Level Expression in Patients with Severe Pneumonic Sepsis and Predictive Value for Heart Failure[J].Journal of Modern Laboratory Medicine,2024,39(01):131.[doi:10.3969/j.issn.1671-7414.2024.03.022]

备注/Memo

备注/Memo:
基金项目：河北省卫生健康委医学课题计划项目（20211402）。
作者简介：李丽霞（1980-），女，汉族，本科，主管检验师，研究方向：临床检验。
通讯作者：李娜（1981-），女，本科，主管检验师，E-mail：65493777@qq.com。
更新日期/Last Update: 2023-01-15